Source link : https://www.newshealth.biz/health-news/surgery-better-than-obesity-drugs-for-some-with-masld/
SAN DIEGO — In patients with metabolic dysfunction–associated steatotic liver disease (MASLD), bariatric surgery appears to carry a lower risk for mortality after 5 years than treatment with pharmacologic therapies such as glucagon-like peptide 1 (GLP-1) receptor agonists or sodium-glucose cotransporter 2 (SGLT2) inhibitors, new study results showed. In a separate analysis of data from […]
Author : News Health
Publish date : 2024-11-25 09:36:23
Copyright for syndicated content belongs to the linked Source.